While Western investment in China slows, Germany’s Bertelsmann has an Asian fund that shows little sign of waning enthusiasm.
Annabelle Long, founding and managing partner of BAI Capital, at the Berlin Global Dialogue in Berlin, Germany, September 28, 2023. Credit: Berlin Global Dialogue
It’s a gloomy time for venture capital in China, with the amount the industry invested in Chinese firms falling to a five-year low last year, according to market intelligence firm S&P Global.
Amid the negative sentiment BAI Capital, part of the German media conglomerate Bertelsmann, has gone against the grain by promising millions of dollars of investments in Chinese start-ups over the next four years.
At The Wire, we periodically focus on prominent firms investing in China, introduc
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
Novo Nordisk, the maker of Ozempic, has enjoyed a China boom in recent years, commanding 77 percent of the market. But that kind of dominance isn’t likely to last, and Novo Nordisk’s challengers in China...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy